TY - JOUR
T1 - Second Colombian Consensus on the Management of Post-menopausal Osteoporosis
T2 - 2017 Update
AU - Más detalles de los autores en el anexo
AU - Medina Orjuela, Adriana
AU - Rosero Olarte, Óscar
AU - Nel Rueda Plata, Pedro
AU - Sánchez Escobar, Fabio
AU - Chalem Choueka, Monique
AU - González Reyes, Miguel Ángel
AU - Román González, Alejandro
AU - Terront Lozano, Alexandra
AU - Páez Talero, Amanda
AU - Rueda Beltz, Camilo
AU - Builes Barrera, Carlos Alfonso
AU - Pérez Niño, Carlos Augusto
AU - Fernández Ávila, Daniel G.
AU - Vásquez Awad, David
AU - González Devia, Deyanira
AU - Pinilla Pabón, Edgar
AU - Reina Valdivieso, Eduardo Antonio
AU - Vásquez Mejía, Esdras Martín
AU - Vargas Grajales, Francisco Iván
AU - Linares Restrepo, Francisco
AU - Altamar Canales, Geraldine
AU - Molina Uribe, Gustavo Adolfo
AU - Pineda Acero, Gustavo Adolfo
AU - Arenas Quintero, Henry Mauricio
AU - Vélez Patiño, Jorge Augusto
AU - Molina Restrepo, José Fernando
AU - Jaller Raad, Juan José
AU - Londoño Gutiérrez, Ricardo
N1 - Publisher Copyright:
© 2018 Asociación Colombiana de Reumatología
PY - 2018/7/1
Y1 - 2018/7/1
N2 - The Colombian Osteoporosis and Mineral Metabolism Association met in early 2017 to update the Colombian Consensus on Osteoporosis. This was first issued in 2005, and is seen as a necessary step in view of the underdiagnosed status of this disease, and the expected impact of population ageing. A technical team was formed with specialists with long experience across multiple disciplines, who were assigned to four working groups: definitions and epidemiology, diagnosis, pharmacological treatment, and non-pharmacological treatment. After a scientific literature review and a series of meetings, the definitions and recommendations are summarised in this article.
AB - The Colombian Osteoporosis and Mineral Metabolism Association met in early 2017 to update the Colombian Consensus on Osteoporosis. This was first issued in 2005, and is seen as a necessary step in view of the underdiagnosed status of this disease, and the expected impact of population ageing. A technical team was formed with specialists with long experience across multiple disciplines, who were assigned to four working groups: definitions and epidemiology, diagnosis, pharmacological treatment, and non-pharmacological treatment. After a scientific literature review and a series of meetings, the definitions and recommendations are summarised in this article.
KW - Bisphosphonates
KW - Bone density
KW - Denosumab
KW - Metabolic bone diseases
KW - Oestrogen replacement therapy
KW - Osteoporotic fractures
KW - Post-menopausal osteoporosis
KW - Practice guideline
KW - Teriparatide
UR - http://www.scopus.com/inward/record.url?scp=85047209328&partnerID=8YFLogxK
U2 - 10.1016/j.rcreu.2018.02.006
DO - 10.1016/j.rcreu.2018.02.006
M3 - Short survey
AN - SCOPUS:85047209328
SN - 0121-8123
VL - 25
SP - 184
EP - 210
JO - Revista Colombiana de Reumatologia
JF - Revista Colombiana de Reumatologia
IS - 3
ER -